Product Information
CARVEDILOL 25 MG TABLET is a generic product labeled by Legacy Pharmaceutical Packaging, LLC, priced at $0.0321 per EA under NDC 68645049659. Its NADAC has been published 574 times since Aug 26, 2015.
FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Carvedilol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Legacy Pharmaceutical Packaging, LLCNDC
68645049659
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARVEDILOLApproval Type
Generic (ANDA)
FDA Application
ANDA077614FDA Approved
9/5/2007
TE Code
AB
On Market Since
9/5/2007
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL 25 MG TABLET has been published 574 times since Aug 26, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0321 per EA |
|---|---|
| All-time high | $0.0422 (Dec 16, 2015) |
| All-time low | $0.0255 (Nov 20, 2024) |
| 52-week high | $0.0323 |
| 52-week low | $0.0311 |
| Median price | $0.0321 |
| Average price | $0.0326 |
| Largest weekly change | +24.5% (Nov 18, 2015) |
| Weeks tracked | 574 |
| Tracking since | Aug 26, 2015 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARVEDILOL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 25 MG TABLET, manufactured by Legacy Pharmaceutical Packaging, LLC, is $0.0321 per EA (NDC 68645049659), effective Aug 19, 2026.
How has the price of CARVEDILOL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARVEDILOL 25 MG TABLET has held within roughly two percent of its current level. It has been tracked across 574 weekly CMS publications since Aug 26, 2015.
What are the highest and lowest recorded NADAC prices for CARVEDILOL 25 MG TABLET?
Since Aug 26, 2015, the NADAC for CARVEDILOL 25 MG TABLET has ranged from a low of $0.0255 (Nov 20, 2024) to a high of $0.0422 (Dec 16, 2015), with a median of $0.0321 per EA.
Are there cheaper alternatives to CARVEDILOL 25 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARVEDILOL 25 MG TABLET, is $0.0319 per EA — about 1% below CARVEDILOL 25 MG TABLET.
Who manufactures CARVEDILOL 25 MG TABLET?
CARVEDILOL 25 MG TABLET (NDC 68645049659) is labeled by Legacy Pharmaceutical Packaging, LLC, and CMS classifies it as a generic product.